IFIH1 (encoding MDA5) mutations reportedly result in aberrant type I IFN expression, leading to AGS (Aicardi–Goutières syndrome), an inflammatory disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, and chilblain skin lesions (12). This evidence concerns the gene IFIH1 and Leukoencephalopathy.